Trials / Unknown
UnknownNCT03627338
Medication Adherence in Patients With Liver Cirrhosis
Medikamentenadhärenz Bei Patientinnen Und Patienten Mit Leberzirrhose
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Hannover Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- —
Summary
With this unfunded, investigator-initiated prospective, observational, explorative, single-arm and diagnostic single-centre study the investigators aim to evaluate medication adherence in patients with advanced liver cirrhosis
Detailed description
The main objective of the study is to investigate drug adherence in cirrhotic patients and to gain a better understanding of the causes of deficient adherence including evaluation for medication beliefs, satisfaction, depression, anxiety and health-related quality of life. A number of long-term medications have been approved for this group of patients in various indications and / or recommended by guidelines. However, adherence has not been adequately investigated yet. The investigators aim to focus on the following groups of ingredients / classes: * Primary and secondary antibiotic prophylaxis (e.g. Norfloxacin) * Non-selective beta-blockers (e.g. Carvedilol and Propranolol) * diuretics (Spirolactones \[e.g. Spironolacton\], loop diuretics) Methodically, this is will be investigated in particular by taking into account the patients history, standardized questionnaires and validated interviews.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | questionaire, interview | questionaire, interview |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2021-03-31
- Completion
- 2021-05-31
- First posted
- 2018-08-13
- Last updated
- 2020-03-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03627338. Inclusion in this directory is not an endorsement.